BABA vs WKSP

The Advanced Deterministic Scorecard reveals a mixed financial profile for Alibaba (BABA), with a weak Piotroski F-Score of 4/9 indicating suboptimal financial health, and no available Altman Z-Score limiting distress risk assessment. While valuation metrics appear favorable relative to peers—especially a Price/Sales of 0.41 and Forward P/E of 19.50—earnings growth is sharply negative (YoY EPS down 71%), and recent quarterly beats have reversed into consistent misses over the last four quarters. Strong insider sentiment and a bullish analyst consensus (strong_buy) contrast with deteriorating profitability and weak technical trends (10/100). The stock trades significantly above the Graham Number ($102.68) and intrinsic value estimate ($51.38), suggesting overvaluation unless growth rebounds materially.

WKSP exhibits critical financial weakness, highlighted by a Piotroski F-Score of 1/9, indicating severe fundamental distress. While the company shows impressive top-line revenue growth of 62% YoY and maintains a healthy current ratio of 2.50, these are overshadowed by a catastrophic profit margin of -120.19% and a 5-year price collapse of 98.2%. The stock trades at a significant discount to book value (P/B 0.47), but the lack of a Graham Number or positive earnings makes it a highly speculative micro-cap play. Despite an optimistic analyst target of $7.00, the deterministic health scores suggest a high risk of continued capital erosion.